01 1Jiangsu Sinopep Allsino Biopharmaceutical
01 1LIRAGLUTIDE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-11-05
Pay. Date : 2019-09-27
DMF Number : 34104
Submission : 2019-09-19
Status : Active
Type : II
20
Sinopep-allsino Biopharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LIRAGLUTIDE, with a corresponding US DMF Number 34104.
Remarkably, this DMF maintains an Active status since its submission on September 19, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 05, 2019, and payment made on September 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
